Revisiting the Antigen-Presenting Function of β Cells in T1D Pathogenesis

Area of Science:

• Immunology
• Endocrinology
• Pathogenesis of Type 1 Diabetes

Background:

• Type 1 diabetes (T1D) is an autoimmune disease characterized by inflammation and destruction of pancreatic islet beta cells.
• Islet-resident antigen-presenting cells (APCs) typically initiate autoimmune responses by presenting beta cell antigens to T cells.
• Beta cell death and autoimmune attack are intertwined processes driving T1D progression.

Purpose of the Study:

• To review the active role of beta cells in initiating autoimmune responses in Type 1 Diabetes.
• To elucidate the mechanisms by which beta cells contribute to the pathogenesis of T1D.
• To highlight the antigen-presenting capabilities of beta cells.

Main Methods:

• Review of existing literature on T1D pathogenesis and beta cell function.
• Analysis of molecular and cellular interactions between beta cells and immune cells.
• Examination of beta cell expression of immune-related molecules.

Main Results:

• Beta cells, under stressed conditions, produce modified neoantigens.
• Upregulated expression of MHC class I/II and co-stimulatory molecules by beta cells mimics professional APCs.
• Beta cells interact with plasmacytoid dendritic cells (pDCs) and activate autoreactive CD4+ and CD8+ T cells.

Conclusions:

• Beta cells are not passive bystanders but actively initiate autoimmune responses in T1D.
• The antigen-presenting function of beta cells contributes to the tissue specificity of T1D.
• Structural cells, like beta cells, play active roles in the pathogenesis of immune-related disorders.